Journal Information

Statistics

Follow this link to access the full text of the article

AO 17
TROCA PARA UM REGIME COM 2 MEDICAMENTOS DOLUTEGRAVIR / LAMIVUDINA (DTG / 3TC) EM DOSE FIXA COMBINADA É NÃO INFERIOR A CONTINUAR COM UM REGIME DE 3 MEDICAMENTOS POR 48 SEMANAS EM UM ENSAIO CLÍNICO RANDOMIZADO (SALSA)
Josep M. Llibrea, Carlos Britesb, Chien-yu Chengc, Olayemi Osiyemid, Carlos Galerae, Laurent Hocquelouxf, Franco Maggiolog, Olaf Degenh, Libby Blairi, Brian Wynnei, James Oyeej, Mark Underwoodi, Lloyd Curtisj, Gilda Bontempoi, Jean van Wykk, Jucival Fernandesl
a Hospital Universitari Germans Trias i Pujol, Barcelona, Espanha
b Universidade Federal da Bahia (UFBA), Salvador, BA, Brasil
c Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan
d Triple O Research Institute PA, West Palm Beach, Estados Unidos
e Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Espanha
f Centre Hospitalier Régional d'Orléans, Orléans, França
g ASST Papa Giovanni XXIII, Bergamo, Itália
h Universitätsklinikum Hamburg-Eppendorf, Hamburgo, Alemanha
i ViiV Healthcare, Research Triangle Park, Estados Unidos
j GlaxoSmithKline, Brentford, Reino Unido
k ViiV Healthcare, Brentford, Reino Unido
l GlaxoSmithKline, Brasil
Ver más
Read
3005
Times
was read the article
1291
Total PDF
1714
Total HTML
Share statistics
Article information
ISSN: 14138670
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 6 19 9 28
2025 5 58 55 113
2025 4 57 30 87
2025 3 50 23 73
2025 2 40 28 68
2025 1 44 39 83
2024 12 35 24 59
2024 11 27 23 50
2024 10 29 31 60
2024 9 33 20 53
2024 8 33 25 58
2024 7 35 33 68
2024 6 42 22 64
2024 5 39 33 72
2024 4 45 30 75
2024 3 65 27 92
2024 2 75 31 106
2024 1 96 34 130
2023 12 73 25 98
2023 11 87 37 124
2023 10 64 33 97
2023 9 47 71 118
2023 8 32 31 63
2023 7 24 29 53
2023 6 32 21 53
2023 5 49 25 74
2023 4 26 21 47
2023 3 56 34 90
2023 2 40 31 71
2023 1 30 19 49
2022 12 53 35 88
2022 11 40 36 76
2022 10 40 23 63
2022 9 35 48 83
2022 8 30 28 58
2022 7 22 29 51
2022 6 28 42 70
2022 5 24 40 64
2022 4 18 32 50
2022 3 25 44 69
2022 2 17 40 57
Show all

Follow this link to access the full text of the article

The Brazilian Journal of Infectious Diseases